Immunodeviation
Zeile 46: | Zeile 46: | ||
'''bacteria''' | '''bacteria''' | ||
{{tp|p=32367857|t=2020. Safety of an immunomodulator Mycobacterium w in COVID-19 |pdf=|usr=}} | {{tp|p=32367857|t=2020. Safety of an immunomodulator Mycobacterium w in COVID-19 |pdf=|usr=}} | ||
+ | |||
+ | '''immunomodulation''' | ||
+ | |||
+ | {{tp|p=32380023|t=ä. Immunomodulation in COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32444269|t=ä. Immunotherapies for COVID-19: lessons learned from sepsis |pdf=|usr=}} |
Version vom 21. Juni 2020, 12:33 Uhr
Macrophages
32335290 2020. A strategy targeting monocyte-macrophage differentiation to avoid pulmonary complications in SARS-Cov2 infection
32374474 2020. Natural antiviral compound silvestrol modulates human monocyte-derived macrophages and dendritic cells
Devvac BCG
32379923 2020. Is BCG vaccination causally related to reduced COVID-19 mortality?
32327396 ä. COVID-19 and Bacillus Calmette-Guerin: What is the Link?
32358227 2020. Demystifying BCG Vaccine and COVID-19 Relationship
32341531 ä. Could BCG be used to protect against COVID-19?
32372835 2020. Trials of BCG vaccine will test for covid-19 protection
32359402 2020. Considering BCG vaccination to reduce the impact of COVID-19
32339299 2020. Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
32330314 2020. Is BCG vaccination affecting the spread and severity of COVID-19?
32295694 2020. COVID-19 vaccination clinical trials should consider multiple doses of BCG
32408071 2020. Relation between BCG coverage rate and COVID-19 infection worldwide
C7136957 ä. Is Global BCG Vaccination Coverage Relevant To The Progression Of SARS-CoV-2 Pandemic?
Devvac Hepatitis A
32279655 2020. Can Hepatitis A Vaccine Provide Protection Against COVID-19?
Devvac Measles
32238614 2020. Measles Immunization: Worth Considering Containment Strategy for SARS-CoV-2 Global Outbreak
Devvac Influenza
32361099 2020. The possible beneficial adjuvant effect of influenza vaccine to minimize the severity of COVID-19
Helminthiosis
32358579 ä. Will helminth co-infection modulate COVID-19 severity in endemic regions?
Devacc
32240961 2020. Routine childhood immunization may protect against COVID-19 |
32387756 2020. SARS ? CoV-2: Reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus, diphtheria and Bordetella pertussis)
anybody remembers old lit on mcns: acacia akazien-extrakt
nothing
Balneotherapy
32300868 ä. Balneotherapy and human immune function in the era of COVID-19
bacteria
32367857 2020. Safety of an immunomodulator Mycobacterium w in COVID-19
immunomodulation
32380023 ä. Immunomodulation in COVID-19
32444269 ä. Immunotherapies for COVID-19: lessons learned from sepsis